Peninsula biopharma wins 1st FDA approval for drug targeting type of brain cancer in kids
The company was supposed to hear back from the FDA next week, but the agency made a rare ahead-of-schedule decision......»»
Sanofi/Regeneron"s Cemiplimab Wins FDA Nod for Skin Cancer
Sanofi (SNY)/Regeneron's (REGN) anti- PD-1 drug cemiplimab wins FDA approval for a type.....»»
FDA grants approval for new drug to treat aggressive breast cancer
The FDA has granted accelerated approval to Immunomedics for a drug used to treat a severe type of breast cancer......»»
Seeking $86 million IPO, this Peninsula company is betting common bacteria plays role in Alzheimer"s
The South San Francisco company is putting its IPO where its mouth is — hoping to take its lead drug, targeting a tooth-loss-causing bacteria that migrates from the mouth to the brain, into a Phase II/III clinical trial soon......»»
Boulder biotech"s melanoma treatment gets FDA approval
A Boulder biotech's combination treatment for a form of skin cancer was approved this week by the U.S. Food and Drug Administration. Array BioPharma Inc. (Nasdaq: ARRY) said its Braftovi capsules in combination with Mektovi tablets has been approved .....»»
Bristol-Myers wins FDA approval for Opdivo as treatment for small cell lung cancer
Bristol-Myers Squibb Co. said Friday the U.S. Food and Drug Admi.....»»
AbbVie"s Rare Blood Cancer Drug Combo Snags FDA Approval
AbbVie Inc (NYSE: ABBV) has received FDA approval of its supplemental New Drug Application for Imbruvica to treat a rare type of cancer. read more.....»»
FDA approves bladder cancer treatment by Culver City company
The Food and Drug Administration on Monday approved Culver City-based ImmunityBio's treatment for a type of bladder cancer.The Food and Drug Administration on Monday approved Culver City-based ImmunityBio's treatment for a type of bladder cancer......»»
Scopus BioPharma submits IND to FDA for lead cancer drug candidate
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
FDA to discuss whether immuno-oncology drugs with "accelerated" approval should remain on the market
The Food and Drug Administration advisory committee plans to hold a three-day meeting this week to evaluate a type of quicker approval used primarily for immuno-oncology drugs that are thought to help .....»»
With pivot to cancer drug company, Peninsula biotech lines up $117M funding
The money represents only the second funding round in the company's 15 years......»»
Tackling deadly newborn disease, BridgeBio affiliate wins FDA drug approval
The BridgeBio model is designed to move drugs tackling rare diseases with a well-defined genetic basis quickly and efficiently to approval......»»
Eli Lilly, Innovent Biologics" Sintilimab Injection Receives China Approval For A Type Of Lung Cancer
read more.....»»
UPDATE: Myovant shares soar 20% premarket on news of Pfizer cancer drug deal worth up to $4.2 billion
Shares of Myovant Sciences soared 20% in premarket trade Monday, after its parent Sumitovant Biopharma said Myovant wi.....»»
Myovant shares soar 16% premarket on news of Pfizer cancer drug deal worth up to $4.2 billion
Shares of Myovant Sciences soared 16% in premarket trade Monday, after its parent Sumitovant Biopharma said .....»»
Raleigh pharma to study coronavirus treatment on patients in U.S.
A Triangle drugmaker that's seen positive results with its Covid-19 treatment internationally can now start treating patients in the U.S. Raleigh's RedHill Biopharma (Nasdaq: RDHL) has received approval from the U.S. Food and Drug Administration .....»»
Novartis wins expanded European OK for Cosentyx amid pursuit of $5 billion sales
Novartis on Wednesday won a new European approval for its inflammation drug Cosentyx in a form of arthritis, as the Swiss drugmaker predicts broadening use of its top-selling medicine will eventually push annual sales beyond $5 billion......»»
CNS Pharma files FDA Orphan Drug Designation for brain cancer drug berubicin
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»